Correction to: Paediatric Recurrent Ear, Nose and Throat Infections and Complications: Can We Do More?

  • PDF / 308,681 Bytes
  • 4 Pages / 595.276 x 790.866 pts Page_size
  • 5 Downloads / 187 Views

DOWNLOAD

REPORT


CORRECTION

Correction to: Paediatric Recurrent Ear, Nose and Throat Infections and Complications: Can We Do More? Ricardo Marengo . Jose´ A. Ortega Martell . Susanna Esposito

 The Author(s) 2020

Correction to: Infect Dis Ther (2020) 9:275–290 https://doi.org/10.1007/s40121-020-00289-3 In the original publication, there was a minor mistake in one of the figures and a number of reference citation numbers were incorrectly published. The figure and citations are corrected here: Page 5/16—Fig. 4 The reference of Fig. 4 is Dang et al. [20] instead Parola et al. [19]. Page 5/16—Downregulation in chronic inflammatory state The sentence ‘‘by decreasing the levels of proinflammatory cytokines (e.g. interleukin [IL]-1b)

in a dose-dependent manner [24]’’ should be referenced by Dang et al. [20] instead of [24]. Page 6/16—Fig. 5 The x axis title on the right side bar in the Fig. 5 should correspond to 10 day post infection and not 5. Page 6/16—Downregulation in Chronic Inflammatory State 1.

The sentence ‘‘and increasing the levels of anti-inflammatory cytokines (e.g. IL-10) [20], thus reducing tissue damage’’ should be referenced by Parola et al. [19] instead of Dang et al. [20].

The original article can be found online at https://doi. org/10.1007/s40121-020-00289-3. R. Marengo ENT and Audiology Department of CEMIC Surgery Department, University Institute CEMIC, Valdenegro, Buenos Aires, Argentina J. A. Ortega Martell (&) Department of Immunology, Universidad Auto´noma del Estado de Hidalgo, Pachuca, Hidalgo, Mexico e-mail: [email protected] J. A. Ortega Martell Consejo Nacional de Inmunologı´a Clı´nica y Alergia, Mexico city, Mexico J. A. Ortega Martell Organizacio´n Mundial de Alergia (World Allergy Organization), Milwaukee, WI, USA

J. A. Ortega Martell Colegio Mexicano de Inmunologı´a Clı´nica y Alergia (CMICA), Mexico city, Mexico J. A. Ortega Martell Colegio Mexicano de Pediatras Especialistas en Inmunologı´a Clı´nica y Alergia (COMPEDIA), Colonia Na´poles, Mexico S. Esposito Pietro Barilla Children’s Hospital, Milan, Italy S. Esposito Department of Medicine and Surgery, University of Parma, Parma, Italy S. Esposito World Association for Infectious Diseases and Immunological Disorders (WAidid), Milan, Italy

Infect Dis Ther

Page 7/16—Efficacy of OM-85 in Children 1.

Fig. 4 Effect of OM-85 on IFN-b production at different concentrations (40 to 640 mcg/ml). The increase on IFNbeta production correspond with the increasing concentration of OM-85. ***p B 0.001. These in vitro results represent mean ± SD (n = 3 techinal replicates). Reference: Dang et al. [20]

2.

Fig. 5 Effect of OM-85 against viral infections in an in vivo infection model. The viral load in lung tissue was determined on day 5 and 10 post-influenza virus infection. Data are representative of 2–5 experiments with 5–10 mice per time point. Error bars represent minimum to maximum value range. Statistical analysis was performed by Student’s t test. ***p \ 0.001. Reference: Pasquali et al. [21]

3.

2.

In the sentence, ‘‘OM-85 may also aid